Multiple sclerosis vaccine (Immune Response BioPharma)

N/A

Report date: 2024/11/02 20:00:07

Base Information

Drug NameMultiple sclerosis vaccine (Immune Response BioPharma)
Drug Alias NameV beta-17多发性硬化症疫苗 - Immune Response BioPharmaNeuroVaxAI-208IR-208 +[6] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmune Response Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmune Response Biopharma Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A